Dr. Smith's research interests are primarily in the area of analysis of outcomes after percutaneous coronary intervention. As the Director of the Cardiac Catheterization Laboratory, he is overseeing the development of our cath lab database system which will provide a wealth of research potential to evaluate various aspects in interventional cardiology. He has worked with Dr. Dennis McNamara in developing a database of coronary intervention patients in which we are currently evaluating the potential genetic basis of cardiac disease. Dr. Smith also serves as the Governor of the Western Pennsylvania Chapter of the American College of Cardiology where he has the unique opportunity to directly impact the practice of cardiology in this region.
Dr. Conrad Smith is the Director of Cardiac Catheterization Laboratory at Presbyterian Hospital of UPMC. His clinical interests are in the areas or interventional cardiology where he has a very active practice in coronary intervention. He also has extensive experience in the treatment of mitral valve stenosis with mitral valvuloplasty, an alternative to surgical therapy for mitral valve disease in selected patients. With his extensive clinical experience, Dr. Smith travels internationally to share his perspectives on the practice of interventional cardiology.
- BS, Stanford University, 1983
- MD, University of California San Francisco School of Medicine, 1987
- MMM, Carnegie Mellon University, 2011
- Residency, Medicine, Massachusetts General Hospital, Harvard Medical School, 1988
- Clinical Fellowship, Cardiology, Massachusetts General Hospital, Harvard Med School, 1990
- Clinical & Research Interventional Fellowship, Cardiology, Massachusetts General Hospital, Harvard Med School, 1992
Education & Training
Olafiranye O, Vlachos HA, Mulukutla SR, Marroquin OC, Selzer F, Kelsey SF, Williams DO, Strollo PJ, Reis SE, Jee JS, Smith AJ. Comparison of long-term safety and efficacy outcomes after drug-eluting and bare-metal stent use across racial groups: Insights from NHLBI Dynamic Registry. Olafiranye O, Vlachos H, Mulukutla SR, Marroquin OC, Selzer F, Kelsey SF, Williams DO, Strollo PJ, Reis SE, Lee JS, Smith AJ. Int J Cardiol. 2015; 184: 79-85.
Chu D, Anastacio MM, Mulukutla SR, Lee JS, Smith AJ, Marroquin OC, Sanchez CE, Morell VO, Cook CC, Lico SC, Wei LM, Badhwar V. Safety and efficacy of implementing a multidisciplinary heart team approach for revascularization in patients with complex coronary artery disease: an observational cohort pilot study. JAMA Surg. 2014; 149(11): 1109-12.
Badhwar V, Smith AJ, Cavalcante JL. A pathoanatomic approach to the management of mitral regurgitation. Trends Cardiovasc Med. 2016; 26(2): 126-34.
Sanchez CE, Badhwar V, Dota A, Schindler J, Chu D, Smith AJ, Lee JS, Khandhar S, Toma C, Marroquin OC, Schmidhofer M, Bhama J, Wei L, Scolieri S, Esper S, Lee A, Mulukutla SR. Practical implementation of the coronary revascularization heart team. Circ Cardiovasc Qual Outcomes. 2013; 6(5): 598-603.
Mulukutla SR, Marroquin OC, Vlachos HA, Selzer F, Toma C, Kip KE, Abbott JD, Holper E, Lee JS, Khandhar S, Kutcher M, Kelsey S, Smith Cq Faxon D, Williams DO. Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry. Am J Cardiol. 2013; 111(4): 486-92.
